Active Pharmaceutical Ingredients Index A to Z

Browse Alphabetically


Also known as: Vulgaris zygis l.

Find overview, chemical composition, chemistry information, uses and benefits details of Thyme active pharmaceutical ingredient in PDF document on PharmaCompass.com.

pdf

Also known as: Valerianae radix

Find overview, chemical composition, chemistry information, uses and benefits details of Valeriana officinalis active pharmaceutical ingredient in PDF document on PharmaCompass.com.

pdf

Also known as: Vitis folium

Find overview, chemical composition, chemistry information, uses and benefits details of Grape seed extract active pharmaceutical ingredient in PDF document on PharmaCompass.com.

pdf

Also known as: Valeriana wallichii, valeriana jatamansii

Dried whole or fragmented underground parts of Valeriana officinalis L.s.l., including the rhizome surrounded by thr roots and stolons.

pdf

Also known as: Agni casti fructus, Chaste tree, Chasteberry, Vitex, Monks pepper

Chasteberry is the fruit of the chaste tree, a small shrub-like tree native to Central Asia and the Mediterranean region. The name is thought to come from a belief that the plant promoted chastity—it...

pdf

Also known as: Luxturna, Voretigene neparvovec rzyl, Vn rzyl

Voretigene Neparvovec-rzyl (VN-rzyl) is an adeno-associated virus vector-based gene therapy.

pdf

Also known as: Entyvio

Vedolizumab (trade name Entyvio) is a monoclonal antibody developed by Millennium Pharmaceuticals, Inc (a subsidiary of Takeda Pharmaceuticals) for the treatment of ulcerative colitis and Crohn\'s disease....

pdf

Also known as: Mepsevii

Vestronidase alfa was FDA-approved on November 17th, 2017 under the trade name Mepsevii as an intravenous infusion for the treatment of pediatric and adult patients.

pdf

Also known as: Veyvondi

Vonicog alfa is indicated for the on-demand treatment and control of bleeding episodes in adults previously diagnosed with von Willebrand disease

pdf

Also known as: Immu-106

A humanized monoclonal antibody directed against the CD20 antigen with potential antineoplastic activity. Following binding, veltuzumab triggers complement-dependent cell lysis (CDCL) and antibody-dependent...

pdf

PharmaCompass >>